Skip to main content

Therapeutics Startups

Updated November 2026

Companies in the therapeutics sector developing innovative solutions and technologies.

Explore 1,733 recently funded therapeutics companies with verified founder contact information and fundraising data.

Total Companies
1,733
Total Funding
$822.6M
Avg Funding
$32.9M
Global Reach
6
countries

Top Cities for Therapeutics

San Francisco
Rockville
New York
Risch
Barcelona
Kyoto

Recently Funded Companies

Export
San Francisco, United States

Vir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions.

$25.0M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

Rockville, United States

Kaigene is a biotechnology company that develops antibody therapeutics through research and preclinical studies.

$55.0M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

New York, United States

Envisagenics reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions.

$2.0M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

Risch, Switzerland

NeuroGyn develops neurostimulation systems and minimally invasive neuromodulation procedures for treating pelvic and systemic disorders.

$4.8M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

Barcelona, Spain

Flavii Therapeutics develops epigenetic therapies for central nervous system disorders with high unmet medical need.

$945K raised
Oct 2026

Founder Contacts

41,000+ verified contacts

Kyoto, Japan

RadioNano Therapeutics is a medical technology company that develops radiation therapy solutions for the treatment of cancer patients.

$955K raised
Oct 2026

Founder Contacts

41,000+ verified contacts

Lausanne, Switzerland

ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.

$86.6M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

San Antonio, United States

BioAffinity Technologies is a cancer diagnostics company that develops non-invasive, early-stage diagnostics to detect cancer and diseases.

$4.0M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Solving disease-related malnutrition with a mobile clinical assistant for healthcare professionals.

$30.0M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

Heverlee, Belgium

Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.

Oct 2026

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Zenflow is a medical company that gives new hope to men suffering from BPH symptoms.

$52.0M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

Baltimore, United States

SereNeuro Therapeutics is a biotechnology business that specializes in revolutionary pain medication research.

Oct 2026

Founder Contacts

41,000+ verified contacts

Tokyo, Japan

Celaid Therapeutics is a biotech company that develops cell therapies for blood cancer, intractable blood diseases, and genetic disorders.

$2.5M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

Wellington, New Zealand

BioOra is a biotechnology company that specializes in revolutionizing cancer immunotherapy services.

$16.8M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

Dallas, United States

OncoNano Medicine is a biotech company that develops pH-activated compounds that digitalize and exploit the variability of pH in disease.

$10.1M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

Tsuruoka, Japan

A clinical-stage company operating Japan’s first GMP-compliant manufacturing platform for fecal microbiota transplantation (FMT) therapies.

$7.7M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Dallas, United States

Lantern Pharma is a clinical stage biopharma company developing precision oncology therapies leveraging A.I., machine learning, and genomics

$4.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Pittsburgh, United States

ai3Bio develops treatments to transform the lives of patients with cancer.

$48.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Menlo Park, United States

AN2 Therapeutics develops small-molecule medicines from boron chemistry for infectious diseases, hematologic disorders, and oncology.

$40.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Palo Alto, United States

ALPFA Medical develops medical devices using pulsed field ablation for prostate treatment.

$30.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Washington, United States

Tern Therapeutics develops transformative, one-time genetic treatments for rare diseases.

$3.7M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

San Mateo, United States

BigHat Biosciences develops antibody and protein therapeutics using machine learning, synthetic biology, and automated experimentation.

$75.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Boulder, United States

Althea is a healthcare and therapeutics company that offers psychedelic programs on health and consciousness.

$2.5M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Florham Park, United States

Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.

$10.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Boulder, United States

Enveda discovers medicines by studying the chemistry of nature and translating natural compounds into potential therapeutic candidates.

$311.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Showing 26 to 50 of 1,733 companies

About the Therapeutics Startup Ecosystem

The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Therapeutics

Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Therapeutics Funding Breakdown

Here is how funding is distributed among the 1,733 therapeutics companies tracked in the VCBacked database.

Average Funding
$32.9M
Total Funding Tracked
$822.6M
Countries Represented
6

Distribution by Funding Stage

Other25 companies

Top Cities for Therapeutics

1.San Francisco
2 companies$55.0M
2.Dallas
2 companies$14.1M
3.Boulder
2 companies$313.5M
4.Rockville
1 companies$55.0M
5.New York
1 companies$2.0M

Related Industries

Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Therapeutics Startups?

Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked